$150.57
-6.02-3.84%
In chiusura: Nov 20, 4:00 PM EST
$150.57
N/A
Post-mercato: Nov 20, 4:00 PM EST

Neurocrine Biosciences (NBIX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $3.29 | $2.59 | 27.0 % |
| Q2 | Jul 30, 2026 | $2.85 | $2.10 | 35.7 % |
| Q1 | May 5, 2026 | $1.94 | $1.61 | 20.5 % |
| Q4 | Feb 11, 2026 | $1.88 | $2.09 | -10.1 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 2, 2026 | $1.12B | $1.04B | 7.29 % |
| Q2 | Jul 30, 2026 | $959.00M | $876.59M | 9.40 % |
| Q1 | May 5, 2026 | $814.50M | $763.11M | 6.73 % |
| Q4 | Feb 11, 2026 | $805.50M | $786.75M | 2.38 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.59 | $2.10 | $1.61 | $2.09 |
| Actual | $3.29 | $2.85 | $1.94 | $1.88 |
| Surprise | +27.0% | +35.7% | +20.5% | -10.1% |
| Revenue | ||||
| Estimate | $1.04B | $876.6M | $763.1M | $786.7M |
| Actual | $1.12B | $959.0M | $814.5M | $805.5M |
| Surprise | +7.29% | +9.40% | +6.73% | +2.38% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.65 | $2.54 | $2.16 | $2.03 |
| Revenue | ||||
| Consensus | $1.09B | $1.06B | — | — |